116 results
Page 4 of 6
8-K
EX-2.1
7yvl3
29 Jan 19
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
8:16am
424B5
nd1ltm
28 Dec 18
Prospectus supplement for primary offering
4:19pm
8-K
EX-10.1
q2vyx8u3qc7zu 85n8f
28 Dec 18
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-1.1
kal1j7sf
28 Sep 18
Aldeyra Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
4:50pm
424B5
oj3km ltu8n9d8o0x4s
28 Sep 18
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.2
cqrcw
25 Sep 18
Aldeyra Therapeutics Announces Positive Mesothelioma Investigator-Sponsored Clinical Trial Results
8:17am
8-K
mgndl08qjgxr1
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:31pm
DEFA14A
bg7ww3hr3nm59z0t
25 Apr 18
Additional proxy soliciting materials
5:25pm